Delivery Order SPE2DB20D3101-SPE2DB24FRMZ1

Award Date 6/17/24
Potential Completion Date 6/18/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus Solostar insulin pens. The contract has a total ceiling value of $1,294.95 and a performance period through May 16, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued at up to $999,999,999.00 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus Solostar 100 unit/ml 3ml insulin pens. The contract has a ceiling value of $4,128.50 and is a firm-fixed price delivery order, with a period of performance ending on May 31, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Lantus Solostar insulin pens. The contract has a ceiling value of $1,781.40 and a period of performance ending on September 9, 2024. The order was placed under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a total potential value of up to $999,999,999 through December 2025...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Lantus Solostar 100 unit/mL 3mL insulin pens, with a ceiling value of $2,361.14 and an ultimate completion date of February 2, 2023. The contract type is Firm Fixed Price, and it was not set aside for any specific business category. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a $1,121.04 delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Lantus Solostar insulin pens. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for the delivery of Lantus Solostar insulin pens. The contract has a ceiling value of $1,768.16 and a completion date of May 22, 2024. It is a firm fixed price delivery order contract, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus SoloStar insulin pens. The contract, valued at $1,979.20, is a firm fixed-price delivery order contract with a period of performance through June 30, 2023. The contract does not have a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Lantus SoloStar 100 unit/mL 3mL insulin pens. The delivery order, valued at $1,185.56, is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical worth $999,999,999. This IDC serves as a primary vehicle for AmerisourceBergen to supply a comprehensive range of pharmaceutical products and...
This federal contract award is for the delivery of Lantus Solostar 100 Unit/ML 3ML insulin pens to the Defense Logistics Agency (DLA). The $1,980.20 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 9, 2024. The contract has an ultimate completion date of December 10, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the procurement of Lantus SoloStar 100 unit/mL 3mL insulin pens. The award has a firm fixed price of $1,991.46 and a completion date of January 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRMZ1
    Delivery Order

This is a Delivery Order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Lantus Solostar insulin pens. The contract has a ceiling value of $1,585.89 and is a Firm Fixed Price arrangement that will run through June 18, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific Delivery Order does not have a set-aside designation, indicating open competition. The contract supports the procurement of critical medical commodities for federal government agencies, including the military and veterans' healthcare systems.

Generated 2/27/25, 1:23 PM